Peer-reviewed medical journal The Lancet has reported that Russia’s Sputnik V vaccine was found to be 91.6% effective against symptomatic COVID-19.
The vaccine was approved by Russian authorities months before final-stage trial results were published, leading to scepticism from industry professionals. However, latest analysis of data from 20,000 phase 3 test participants suggests the vaccine’s 90% efficacy versus symptomatic COVID-19.
Independent commentators highlighted that while being primarily criticised for corner-cutting and lack of transparency, the report’s outcome is clear that the vaccine “can join the fight to reduce the incidence of COVID-19.”
#MaltaDaily